
Surgical Robotics Market Size, Share, Trends & Global Forecast 2026–2035
The Surgical Robotics Market is Segmented By Offering (Instruments & Accessories, Robotic Systems [Laparoscopic, Orthopedic, Neurosurgical, Other Robotic Systems], Services), By Application (General Surgery, Gynecological Surgery, Orthopedic Surgery, Urological Surgery, Neurosurgery, Microsurgery, Otological Surgery, Other Applications), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) and Region
Surgical Robotics Market Overview and Definition
The Global Surgical Robotics Market was valued at USD 13.69 Billion in 2025 and is projected to reach USD 53.96 Billion by 2035, growing at a CAGR of 14.70% from 2026 to 2035. This market encompasses robotic-assisted surgical systems, instruments, accessories, and integrated services enabling minimally invasive surgical procedures across multiple specialties. North America dominates the market due to advanced healthcare infrastructure, well-established regulatory pathways, and high surgeon adoption rates.
General surgery and orthopaedic surgery represent the dominant application segments, whilst robotic systems drive market value. The forecast period anticipates accelerated adoption across emerging markets, technological advancement in platform capabilities, development of competing platforms from new manufacturers, and expansion of robotic-assisted procedures into underserved surgical specialities. Rising patient demand for minimally invasive approaches, improved clinical outcomes, and reduced recovery times underpin sustained market expansion through 2035.
Key Market Trends & Analysis
- The Global Surgical Robotics Market was valued at USD 13.69 billion in 2025, establishing a strong foundation for sustained market expansion through 2035.
- Market is projected to reach USD 53.96 billion by 2035, representing substantial value creation and widespread adoption across global healthcare systems.
- CAGR of 14.70% from 2026 to 2035 reflects strong demand for minimally invasive surgical technologies and emerging market growth opportunities.
- Robotic systems generate the highest market value, whilst instruments and accessories form the largest market share by volume.
- North America accounts for the largest share of global market value, establishing clear regional market concentration and leadership position.
- General surgery dominates application segments, driven by increasing procedural volume and clinical evidence validation.
- Hospitals remain the dominant end-user segment due to facility investment capacity and high procedural volume.
- USA market valued at approximately USD 5.0 billion in 2025, projected to reach USD 10.5 billion by 2035, growing at CAGR of approximately 15.6%.
- Asia-Pacific is the fastest-growing region, advancing at approximately 15.4% CAGR from 2026 to 2035, driven by infrastructure expansion and surgical procedure growth.
- Germany leads Europe with strong robotic-assisted surgery adoption and advanced healthcare systems integration.
- China demonstrates rapid market expansion reflecting hospital network growth and rising chronic disease burden.
- Orthopaedic surgery and gynaecological surgery together represent substantial application-based market value within the global market.
- Competitive landscape dominated by Intuitive Surgical, Stryker, and Medtronic, with new platforms from CMR Surgical and others fragmenting market share.
The surgical robotics market is a market that includes hardware, software, instrumentation, accessories and services used in robotic surgery. Key products include robotic-assisted surgical systems for use in general, orthopaedic, urology, neurosurgery, gynaecology and microsurgery. Products include laparoscopic systems, orthopedic robotic systems, neurosurgical systems and combined systems.
Accessories and instruments include end effectors, energy sources, tissue containment, trocars and sterilisation supplies. Services include installation, training, servicing, warranties, funding and technical support. This market includes capital items and consumables. End users are hospitals, specialist surgery centres, day surgery centres and teaching hospitals. This market covers North America, Europe, Asia-Pacific and Latin America. Innovations in this market also include regulation, reimbursement, training and demand from patients.
Surgical robotics provides essential improvements to healthcare by providing precision, efficiency, reducing costs and improving outcomes. This improves the quality of surgery by giving surgeons greater control, precision, magnification and reducing hand tremors. Using minimally invasive robotic surgery reduces recovery times, hospital stays and complications. Hospitals invest in robotic surgery to help stand out from the competition, increase patient numbers, improve productivity for the surgery team and optimise theatre usage.
Source: Kaiso Research and Consulting
This market is constantly innovating. Software is becoming more advanced with increased data analysis. Procedures are becoming wider ranging and new platforms are being developed to compete. Regulations are also constantly changing to aid innovation. Reimbursements are increasing to help show the value these procedures can add. Opportunities are increasing with AI, telesurgery, reduced robotic size and new robotic systems for specific areas to help target unmet needs.
In December 2025, CMR Surgical achieved FDA 510(k) clearance for its Versius Plus robotic system, enabling cholecystectomy procedures and establishing a significant new competitive platform in the USA market.
Recent Developments in the Surgical Robotics Market
- In December 2025, CMR Surgical Ltd., a Cambridge, United Kingdom-based surgical robotics manufacturer, announced that the FDA had granted 510(k) clearance for its Versius Plus next-generation robotic surgical system for cholecystectomy procedures. The company stated it is on track to begin USA market commercialisation in 2026. The Versius Plus platform incorporates a flexible modular design and data-driven digital ecosystem, including Versius Connect surgeon application and Versius Team live dashboard for tracking surgical team performance, case volume and system efficiency. This clearance represents the second FDA marketing authorisation for CMR Surgical, following de novo approval of the first-generation Versius system in October 2024, and significantly expands competitive options within the USA soft-tissue surgical robotics market.
- In December 2025, Medtronic plc announced that the USA FDA had granted clearance for the Hugo robotic-assisted surgery system for urologic surgical procedures, including transurethral resection of the prostate. The system represents Medtronic's strategic entry into the soft-tissue robotic-assisted surgery market, competing directly with established platforms from Intuitive Surgical and new entrants including CMR Surgical. Hugo incorporates advanced visualisation, instrument control and haptic feedback technology designed to enhance surgical precision and procedural efficiency. The FDA clearance establishes an important competitive milestone and expands hospital options for robotic-assisted urology programmes, supporting market expansion and fostering technology innovation across the surgical robotics sector.
- In February 2026, THINK Surgical Inc., a specialist orthopaedic surgical robotics company, announced that it had completed the first-ever surgical cases combining its TMINI Miniature Robotic System with Stryker's Triathlon Knee System for total knee arthroplasty procedures. The clinical deployment demonstrated advanced technological integration linking robotic navigation capabilities with orthopaedic implant systems, expanding precision possibilities within knee replacement surgery. The milestone represents strategic collaboration between robotic and implant manufacturers and validates emerging platform integration approaches that combine robotic guidance with surgical hardware, opening new opportunities for orthopaedic surgical outcomes improvement and market expansion.
- In November 2025, IMPLANET SA, a France-based orthopaedic implant manufacturer, announced a new strategic partnership agreement with 8i Robotics Inc., a developer of surgical robotics technology. The collaboration focuses on developing integrated orthopaedic robotic solutions combining IMPLANET's implant portfolio with 8i Robotics' robotic guidance and navigation capabilities. This partnership represents an important European innovation initiative supporting competitive platform development and strengthening the continent's position in the rapidly expanding surgical robotics market whilst offering European healthcare facilities enhanced technology options.
- In March 2026, Apollo Hospitals Chennai, a major Indian healthcare provider, launched the Apollo Institute of Robotics & Telesurgery (ART), a dedicated innovation centre designed to advance robotic-assisted surgery, digital surgery platforms and remote surgical collaboration across India and the Asia-Pacific region. The facility represents significant investment in surgical robotics infrastructure, surgeon training and research, supporting market development and technology adoption across the fastest-growing regional market. The initiative positions India and Asia-Pacific as important centres for surgical robotics innovation and training, driving competitive knowledge development and expanding access to advanced surgical technologies.
Surgical Robotics Market Dynamics: Drivers, Restraints, Opportunities, Challenges and Trends
Drivers: Minimally invasive surgical demand accelerates adoption of precision robotic-assisted platforms across global healthcare systems.
Surgeon and patient preference for minimally invasive surgical approaches continues strengthening, driven by evidence demonstrating reduced recovery times, lower complication rates and improved clinical outcomes compared to traditional open procedures. Robotic-assisted systems enable enhanced surgical precision, improved instrument dexterity and magnified surgical field visualisation, supporting minimally invasive approach adoption across general surgery, orthopaedic and urological applications. Healthcare systems increasingly recognise minimally invasive procedures as competitive differentiators, attracting patient demand and supporting facility reputation.
Surgeon training in robotic-assisted techniques continues expanding globally, building procedural experience and confidence. The clinical evidence base supporting robotic-assisted procedures across multiple specialities continues strengthening, facilitating reimbursement policy alignment and hospital investment justification. Market dynamics reflect strong underlying demand momentum for technology enabling the minimally invasive surgery paradigm shift, providing sustained growth drivers throughout the forecast period.
Restraints: Capital acquisition costs and infrastructure requirements present significant barriers to facility adoption of advanced robotic platforms.
Robotic surgical systems require substantial capital investment, limiting availability to well-capitalised healthcare facilities and established hospital networks. Installation, facility modification, operating room redesign and infrastructure upgrades create additional capital requirements and implementation complexity. Surgeon training requirements, credentialing processes and initial learning curves create operational barriers and procedural inefficiency during platform adoption periods.
Supply chain disruptions affecting component sourcing, manufacturing and equipment delivery create intermittent availability constraints. Skilled technical maintenance, software updates and cybersecurity requirements necessitate ongoing operational expertise and support infrastructure. Regulatory approval pathways remain complex and lengthy in certain jurisdictions, delaying technology availability and limiting market access. Geographic disparities in reimbursement policy and insurance coverage create market fragmentation and limit adoption predictability across regions.
Opportunities: Emerging market infrastructure development and rising surgical procedure demand create substantial expansion opportunities across Asia, Latin America and Africa.
Asia-Pacific region experiences rapid healthcare infrastructure expansion, hospital network growth and rising surgical procedure volumes driven by ageing demographics and increasing chronic disease prevalence. China, India and Southeast Asian countries represent high-growth opportunities characterised by expanding private hospital investment, rising healthcare expenditure and surgeon training development. Latin America demonstrates growing private healthcare infrastructure, medical tourism development and increasing robotic-assisted surgery adoption within major urban centres. Africa experiences gradual healthcare modernisation and facility upgrade initiatives creating emerging opportunities for platform deployment in major medical centres.
Ambulatory surgical centres represent underutilised deployment opportunities across North America and Europe, offering cost-effective facilities for robotic platform installation and specialised procedure development. Expansion into emerging surgical applications including general surgery, gynaecological and thoracic procedures opens new market segments beyond established orthopaedic and urological applications. Artificial intelligence integration, real-time surgical analytics and data-driven outcome tracking create differentiated value propositions supporting premium pricing and market segmentation.
Challenges: Reimbursement policy variation and clinical evidence validation requirements create uncertain adoption timelines across diverse healthcare systems.
Insurance coverage policies, government reimbursement rates and hospital economics vary significantly across jurisdictions, creating adoption uncertainty and limiting predictable market expansion. Clinical evidence requirements for procedure validation, health technology assessments and cost-effectiveness studies extend regulatory and reimbursement timelines. Healthcare system consolidation, budget constraints and competing capital priorities limit facility investment capacity for new technology platforms.
Surgeon resistance, learning curve complexity and established practice inertia create adoption barriers within systems traditionally reliant on open surgical techniques. Competing technology platforms from established manufacturers and new entrants fragment market share and intensify competitive pricing pressures. Cybersecurity vulnerabilities, data privacy requirements and regulatory compliance complexity create operational and liability risks. Supply chain concentration, component sourcing constraints and manufacturing capacity limitations create intermittent availability challenges restricting market growth.
Trends: Competitive platform proliferation and technology specialisation drive market segmentation and innovation acceleration across surgical robotics sector.
Established manufacturers including Intuitive Surgical, Stryker and Medtronic face increasing competition from new entrants including CMR Surgical, THINK Surgical and emerging Asian manufacturers offering alternative platforms and cost-competitive options. Technology specialisation supports development of application-specific platforms optimised for orthopaedic, general surgery, urological and neurosurgical procedures rather than generalised multi-application systems. Artificial intelligence and machine learning integration enables real-time surgical guidance, automatic instrument movement refinement and post-operative outcome prediction supporting procedural excellence.
Software and digital ecosystem development creates data analytics capabilities, procedure documentation and surgical team performance tracking generating competitive differentiation through information value. Remote surgical capabilities and telemedicine integration enable geographic procedure distribution and specialist access expansion in resource-constrained regions. Miniaturisation of robotic components and development of single-port and hand-held robotic systems expand accessibility and reduce facility infrastructure requirements. Strategic partnerships between robotic manufacturers and implant companies, digital surgery platforms and healthcare information systems create integrated solutions addressing system-wide surgical care workflow optimisation.
Where Are the Biggest Opportunities in the Surgical Robotics Market?
- Asia-Pacific market expansion through infrastructure investment, hospital network growth and rising surgical procedure demand across China, India and Southeast Asia.
- Ambulatory surgical centre adoption driving facility-level deployment opportunities and specialised procedure development within cost-conscious healthcare environments.
- General surgery application expansion beyond established gynaecological and urological procedures into emerging specialties and underserved procedural categories.
- Artificial intelligence and machine learning integration enabling real-time surgical guidance, outcome prediction and performance analytics supporting premium value positioning.
- Emerging market penetration in Latin America and Africa through medical device financing innovations and partnership development with healthcare infrastructure providers.
- Single-port and hand-held robotic system development reducing facility infrastructure requirements and enabling deployment within specialty clinics and ambulatory centres.
- Remote surgical capabilities and telemedicine integration supporting specialist access expansion and geographic procedure distribution in resource-constrained regions.
- Neurosurgery and cardiac surgery application development opening high-value specialised procedure markets with distinct clinical and economic value propositions.
- Reimbursement policy optimization through health technology assessment partnerships demonstrating clinical and economic value supporting premium pricing and adoption velocity.
- Strategic partnerships with digital surgery platforms, imaging technology providers and healthcare information systems enabling integrated solutions addressing system-wide surgical workflow optimisation.
Surgical Robotics Market Segmentation Analysis
Report Attributes | Details |
Market Size in 2025 | USD 13.69 Billion |
Market Size by 2035 | USD 53.96 Billion |
CAGR (2026-2035) | 14.70% |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Historical Data | 2022-2024 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, Analysis, Forecast Outlook |
Key Segments | By Offering:
By Application: General Surgery, Gynecological Surgery, Orthopedic Surgery, Urological Surgery, Neurosurgery, Microsurgery, Otological Surgery, Other Applications By End User: Hospitals, Specialty Clinics, Ambulatory Surgery Centers |
Regional Analysis/Coverage | North America (U.S, Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, rest of Asia Pacific), LAMEA (Latin America, Middle East, and Africa) |
Company Profiles | Intuitive Surgical (US), Stryker (US), Medtronic (US), Smith+Nephew (UK), Zimmer Biomet (US), Siemens Healthineers AG (Germany), Renishaw Plc (UK), Johnson & Johnson (US), Globus Medical, Inc (US), CMR Surgical (UK) |
Source: Kaiso Research and Consulting
Surgical Robotics Market Segment Analysis
- By Offering, Robotic Systems dominated the Surgical Robotics Market in 2025 with approximately 58% share; Instruments & Accessories is the fastest-growing offering segment with a CAGR of approximately 15.2% from 2026 to 2035.
- By Application, General Surgery dominated the Surgical Robotics Market in 2025 with approximately 35% share; Orthopedic Surgery is the fastest-growing application segment with a CAGR of approximately 16.1% from 2026 to 2035.
- By End User, Hospitals dominated the Surgical Robotics Market in 2025 with approximately 70% share; Ambulatory Surgery Centers is the fastest-growing end-user segment with a CAGR of approximately 17.3% from 2026 to 2035.
Dominating Segments in the Surgical Robotics Market
By Offering: Robotic systems establish market value dominance through capital-intensive platform deployment and surgical precision capability.
The robotic segment constitutes the largest portion of the offering with around 58%. This is due to the significant capital that is required to purchase surgical robotic platforms. The largest sub-segment is the laparoscopic platforms within general surgery. Orthopaedic robotic navigation and neurosurgical robotic systems are also prominent. There is strong demand for these as they are proven within clinical settings and are now used widely within hospitals.
The segment with the highest growth is the instruments and consumables segment at around 15.2% CAGR. This is due to the increase in procedures being performed. With more robotic-assisted procedures being performed there has been an increased demand for specific instruments and spare parts. This means that there is a steady increase in revenue streams from the increasing number of platforms in use. The services segment also benefits from the increase in systems within use. However, robotic systems still remain the largest segment due to having established themselves. There has been increased investment from healthcare facilities into major capital equipment.
In March 2026, CMR Surgical announced that its Versius surgical robotic system had treated more than 45,000 patients globally, demonstrating growing platform adoption and market expansion across multiple geographic regions.
By Application: General surgery dominates application segments through high procedural volume, clinical evidence validation and surgeon training expansion.
General Surgery dominated the application segment with around 35% market share in 2025 due to a high volume of procedures performed. This is due to the wide range of procedures general surgery can be applied for including cholecystectomy, hernia repair and bariatric surgeries. It has become a strong market leader due to the integration of robotic technology in many procedures and is widely used. The well-established reimbursement mechanisms plus hospitals investing in minimally invasive surgery has also contributed to general surgery being a key application segment.
Orthopaedic surgery is the fastest growing application segment with around a 16.1% CAGR. This is due to an increase in robotic technology being used in knee and hip replacement. Robotic technology is also being used in spinal surgery plus more private hospitals are investing in these procedures in Asia-Pacific and Europe. Gynaecology and Urology have been established in the market however, Neurology is starting to grow due to robotic technology offering precise guidance during procedures.
General surgery will remain the market leader during the forecast period due to its variety of applications, large volumes of procedures and well-established reimbursement structures. Demand for minimally invasive procedures is growing across all surgical areas. This means robotic technology is becoming more relevant to surgeons due to providing more accurate surgeries and quicker recovery times. With a continued focus on improving patients outcomes, the market is likely to grow across hospitals, specialist centres and other healthcare facilities.
In February 2026, THINK Surgical completed first clinical cases integrating its TMINI robotic system with Stryker's Triathlon Knee implant system, expanding orthopaedic robotic capabilities and accelerating fastest-growing application segment expansion.
By End User: Hospitals establish end-user dominance through financial capacity, procedural volume and comprehensive surgical specialisation coverage.
The hospitals segment dominated the market with around 70% share due to their ability to invest in such an expensive treatment. With high volumes of surgical procedures being performed, this increases the return on investment. This means hospital will continue to invest in robotic surgery. Hospitals have well established infrastructure, experienced surgeons and advanced medical technology which will increase demand from this segment. They will be able to offer multiple types of surgeries due to having a variety of different surgical specialties.
Ambulatory Surgery Centres (ASC) are the fastest growing segment of the market with growth projected at around 17.3% CAGR. This is due to increased investment into specialty robotic systems. ASCs have increased efficiency due to their specialist nature, as well as being cost effective. Specialist clinics are also increasing their use of robotic surgery.
Whilst hospitals are still the largest segment, ASCs have been increasing due to their specialist nature. Demand for minimally invasive surgery in an outpatient setting has also increased. As technology continues to improve and financing becomes more flexible, this will decrease any barriers to entry and allow robotic surgery to become more accessible to hospitals, outpatient centres and specialty clinics.
In March 2026, Apollo Hospitals Chennai established the Apollo Institute of Robotics & Telesurgery (ART), a dedicated facility advancing robotic-assisted surgery and remote surgical collaboration across Indian hospitals and emerging markets.
Regional Insights in the Surgical Robotics Market
Regional Analysis:
Region | Major Country | Share within Region, 2025 (%) |
North America | USA | 56% |
Europe | Germany | 32% |
Asia Pacific | China | 48% |
Latin America | Brazil | 35% |
North America: Advanced healthcare infrastructure and established regulatory frameworks drive sustained surgical robotics adoption across the region.
The North American surgical robotics market has had the largest share globally and is set to grow at an impressive CAGR of around 14.5% during the forecast period (2026-2035). Within this market, the US has the largest share accounting for around 56% of total North American market share. There is great leadership within the region due to its advanced healthcare infrastructure, established reimbursement and the highest surgeon training. The region benefits from strong healthcare regulations, like FDA approval routes and established reimbursement. Investment in research facilities and innovation within health care technology has enabled the region to have a strong competitive advantage. Minimally invasive procedures are seen as a competitive advantage within healthcare facilities.
There is a good environment in terms of investment in healthcare both publicly and privately, there is also good insurance available to cover procedures and regulations that help technologies to be developed. Locally there is innovation within advanced platforms, incorporating AI and haptics. Opportunities exist within the region to expand into ambulatory surgery centres, develop next generation platforms and incorporate telesurgery. There is a mature supply chain and medical devices manufacturing infrastructure to enable efficient deployment of platforms.
In May 2026, Intuitive Surgical reported strong first-quarter earnings, demonstrating continued market confidence and accelerating adoption of da Vinci robotic systems across North American healthcare facilities and surgical specialties.
USA: Surgeon training capacity and comprehensive reimbursement policies establish the foundation for sustained surgical robotics market expansion.
The USA Surgical Robotics market was worth USD 5.0 billion in 2025 and is forecast to be worth USD 10.5 billion by 2035. This equates to a CAGR of 15.6% between 2026 and 2035. The USA accounts for around 56% of the North American market. It has a large share in the global market due to its early take-up of minimally invasive surgery, high healthcare spend and strong evidence base.
The health care industry has well established centres for surgery with continued innovation from Intuitive Surgical, Medtronic, Stryker and CMR Surgical. There is good Federal and private funding for robotic-assisted procedures in some areas which has increased hospital investment. Large academic medical centres have led to good progress in training surgeons.
Technology within the market is being heavily invested in by hospitals to update systems, incorporate digital technology and automation. Government investment aims to improve the quality of health care with funding for minimally invasive surgery. Opportunities exist to further develop robotic platforms for use in general surgery, next generation platforms at competitive prices and remote surgery. The USA market impacts the global market.
In December 2025, Medtronic received FDA clearance for its Hugo robotic-assisted surgery system for urologic surgical procedures, expanding competitive options available to USA hospitals and strengthening market segmentation.
Europe: Rigorous health technology assessments and collaborative surgical innovation drive steady robotic surgery adoption across regulated healthcare systems.
The European market is the second largest market for surgical robots and is expected to grow at a CAGR of around 14.0% between 2026 and 2035. Germany accounts for approximately 32% of the market share. This is due to Germany having advanced healthcare facilities and are leading the way for adoption of minimally invasive surgery. This is further driven by the fact that there is evidence based medicine in place, strict regulation in place including CE mark and innovative research. Investment within healthcare is focused on improving efficiency and patient outcomes.
The major countries are Germany, United Kingdom, France and Italy, who have the highest numbers of procedures and adoption rates. There have been innovations within these countries, with companies such as CMR Surgical (United Kingdom) and avateramedical (Germany) producing their own robots meaning hospitals can choose from different options. There is strong government investment, public and private investment within healthcare. This has led to opportunities such as expansion on robotic surgery within public healthcare, value based purchasing and creation of specialist training centres for surgical techniques.
In November 2025, IMPLANET announced a strategic partnership agreement with 8i Robotics Inc., strengthening European innovation capabilities in surgical robotics and expanding access to advanced robotic-assisted platforms across European healthcare networks.
Asia-Pacific: Rapidly expanding healthcare infrastructure and rising surgical procedure demand position the region as the fastest-growing surgical robotics market globally.
Asia Pacific is the fastest growing regional market for the product, growing at around 15.4% CAGR between 2026-2035. China accounts for around 48% of the market across Asia Pacific due to increased hospital networks, an increase in surgical indications and government initiatives to boost the healthcare industry. This is being supported by increased investments into private healthcare within the region, increased clinical data and an increase in patient awareness.
Japan and India are also key markets for growth. The policy and investment landscape is heavily supported by government investment to boost healthcare infrastructure, hospitals and medical technologies. Innovation is being focussed on creating affordable and accessible robotics platforms. This will be driven by increased capacity within large metropolitan surgical hubs, surgeon training and certification programs and the introduction of telehealth and remote surgery.
In March 2026, Apollo Hospitals Chennai launched the Apollo Institute of Robotics & Telesurgery (ART), establishing a dedicated innovation centre for advancing robotic surgery and remote surgical collaboration across India and Asia-Pacific.
Japan: Technological leadership in precision manufacturing and ageing demographics drive robotic surgery adoption within Asia-Pacific's most mature market.
Japan plays a key role in the Asia Pacific region and has shown a CAGR of around 11.31% between 2026 and 2035. It also represents around 15% of the Asia Pacific market. Japan has a well-developed healthcare industry, with many facilities. This means there are plenty of trained surgeons and the technology has been adopted in general, urology and neurology. The ageing population has increased the number of surgeries being performed which has resulted in an increase in demand for Minimally Invasive Surgery. The healthcare industry in Japan places great importance on accuracy, safety and evidence based treatments.
Leading robotic surgery programs have been developed by major medical centres and Universities. There are good policies and investments in place due to government funding in healthcare, private hospitals investing in robotic surgery and a favourable regulatory environment. Innovation in the region is focussed on creating accurate robotic platforms. Opportunities within the region include increasing the number of robotic surgery training centres, creating specific platforms for different applications and working with domestic and international manufacturers.
In February 2026, THINK Surgical completed first surgical cases using its TMINI Miniature Robotic System in combination with the Triathlon Knee System from Stryker, demonstrating advanced orthopaedic robotic capabilities and expanding treatment options available to Japanese surgical centres.
LAMEA: Emerging healthcare infrastructure investment and rising chronic disease burden create early-stage opportunities for surgical robotics expansion across developing regions.
This is an emerging region within the global Surgical Robotics Market, growing at a CAGR of Approximately 12.0% between 2026 and 2035. Brazil makes up Around 35% of the LAMEA market, with increased private healthcare facilities and growing adoption of medical devices in major cities. The United Arab Emirates is also an important market within the region with increasing modernisation of their health care system. Overall the region will see steady growth due to improvements in facility infrastructure, increased investment in private healthcare and training for surgeons.
Healthcare regulations are also increasing within the region, facilitating approvals for devices. The policies and investments reflect a drive from governments to increase the modernisation of their healthcare systems, increased healthcare facility expansion and increased adoption of medical technology. Innovation within the region is focussed on making robotic systems more accessible to fit with the economic situation. Opportunities exist to increase robotic surgery capabilities within major cities, develop finance/leasing solutions to invest in facilities, provide training for surgeons and staff and collaborate with local healthcare providers and established surgical robot companies.
In October 2025, Panda Surgical completed a significant funding round supporting expanded development of its handheld neurosurgical robot, advancing innovative robotic platforms accessible to emerging market healthcare systems and underserved surgical specialities.
How Can Stakeholders Benefit from the Surgical Robotics Market Report?
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

